Euclidean Technologies Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-39,376
Closed -$2.09M 95
2022
Q4
$2.09M Buy
39,376
+15,829
+67% +$858K 1.99% 21
2022
Q3
$1.32M Hold
23,547
1.48% 45
2022
Q2
$1.7M Hold
23,547
1.76% 34
2022
Q1
$1.87M Hold
23,547
1.73% 39
2021
Q4
$2.38M Sell
23,547
-1,885
-7% -$188K 1.99% 15
2021
Q3
$2.35M Hold
25,432
2.04% 14
2021
Q2
$2.6M Buy
25,432
+459
+2% +$46.1K 2.08% 6
2021
Q1
$2.44M Hold
24,973
2.12% 15
2020
Q4
$1.93M Buy
24,973
+3,005
+14% +$232K 2.03% 22
2020
Q3
$1.62M Buy
21,968
+2,733
+14% +$219K 2.04% 13
2020
Q2
$1.41M Buy
+19,235
New +$1.51M 1.98% 23
2016
Q1
Sell
-1,600
Closed -$102K 64
2015
Q4
$102K Hold
1,600
0.11% 56
2015
Q3
$107K Sell
1,600
-2,600
-62% -$184K 0.11% 53
2015
Q2
$287K Sell
4,200
-38,816
-90% -$2.46M 0.27% 51
2015
Q1
$2.39M Sell
43,016
-26,448
-38% -$1.36M 2.18% 18
2014
Q4
$3.56M Sell
69,464
-37,336
-35% -$1.83M 3.33% 17
2014
Q3
$3.93M Buy
106,800
+2,600
+2% +$93.8K 3.66% 3
2014
Q2
$4.07M Sell
104,200
-9,200
-8% -$341K 3.6% 7
2014
Q1
$4.27M Buy
113,400
+28,848
+34% +$1.01M 3.74% 4
2013
Q4
$3.19M Buy
+84,552
New +$3.24M 2.92% 25

Other funds holding USNA

Euclidean Technologies Management's USNA Position: Q1 2023 in Review

Euclidean Technologies Management sold out of Usana Health Sciences (USNA) in Q1 2023, closing a stake of 39,376 shares — an estimated $2.09M sold.

Euclidean Technologies Management first reported a position in USNA in Q4 2013 and held it in 20 quarters. The position peaked at $4.27M in Q1 2014. 176 funds tracked by Wall St. Rank hold USNA as of Q1 2023.

  • Euclidean Technologies Management reported no remaining Usana Health Sciences position as of Q1 2023 after selling out during the quarter.
  • Euclidean Technologies Management sold 39,376 Usana Health Sciences shares in Q1 2023, an estimated $2.09M.
  • Euclidean Technologies Management first reported a position in Usana Health Sciences in Q4 2013 and held it in 20 quarters.
  • Euclidean Technologies Management's Usana Health Sciences position peaked at $4.27M in Q1 2014.
  • 176 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2023.

Based on Euclidean Technologies Management's 13F filing for Q1 2023, filed 26 Apr 2023.